[pending] GANIRELIX ACETATE (GANIRELIX ACETATE)
Pending LLM rewrite. Source: FDA_DRUG D-0220-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
The recalled product
- Product
- GANIRELIX ACETATE (GANIRELIX ACETATE)
- Brand
- GANIRELIX ACETATE
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: WB00006
- Exp 12/31/2026
UPCs (1)
- 0370748274019
Distribution
Distributed in 4 states:
- FL
- MA
- MI
- OH
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27